Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Eargo Inc is a medical devices business based in the US. Eargo Inc shares (EAR) are listed on the NASDAQ and all prices are listed in US Dollars. Eargo Inc employs 243 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $0.76 |
|---|---|
| 52-week range | $0.72 - $39.09 |
| 50-day moving average | $1.80 |
| 200-day moving average | $5.10 |
| Wall St. target price | $10.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-4.46 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.757 from 2022-07-01
| 1 week (2022-06-28) | -22.13% |
|---|---|
| 1 month (2022-06-03) | -41.32% |
| 3 months (2022-04-04) | -85.93% |
| 6 months (2022-01-06) | -89.60% |
| 1 year (2021-07-06) | -98.04% |
|---|---|
| 2 years (2020-07-02) | N/A |
| 3 years (2019-07-02) | N/A |
| 5 years (2017-07-02) | N/A |
| Revenue TTM | $19.3 million |
|---|---|
| Gross profit TTM | $4.2 million |
| Return on assets TTM | -60.43% |
| Return on equity TTM | -153.7% |
| Profit margin | 0% |
| Book value | $1.06 |
| Market capitalisation | $29.8 million |
TTM: trailing 12 months
We're not expecting Eargo Inc to pay a dividend over the next 12 months.
Eargo, Inc. , a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
